Open access
Open access
Powered by Google Translator Translator

ALA/ATS Response to Philip Morris International’s (PMI) Purchase of British Producer of Respiratory Treatments – “The announcement that PMI wants to acquire an inhaled medicine company is the latest reprehensible choice from a company that has profited from addicting users to its deadly products”.

20 Jul, 2021 | 10:12h | UTC

American Lung Association and the American Thoracic Society Response to Philip Morris International’s Purchase of British Producer of Respiratory Treatments – American Thoracic Society

 


Stay Updated in Your Specialty

No spam, just news.